PTF1A and diabetes mellitus: In an additional proband, we found two novel compound heterozygous variants in the enhancer region of PTF1A. Even though one variant did not fulfil criteria for pathogenicity according to ACMG guidelines, it is possible that these variants may be the cause of diabetes in this participant.